Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.

van der Lee SJ, Conway OJ, Jansen I, Carrasquillo MM, Kleineidam L, van den Akker E, Hernández I, van Eijk KR, Stringa N, Chen JA, Zettergren A, Andlauer TFM, Diez-Fairen M, Simon-Sanchez J, Lleó A, Zetterberg H, Nygaard M, Blauwendraat C, Savage JE, Mengel-From J, Moreno-Grau S, Wagner M, Fortea J, Keogh MJ, Blennow K, Skoog I, Friese MA, Pletnikova O, Zulaica M, Lage C, de Rojas I, Riedel-Heller S, Illán-Gala I, Wei W, Jeune B, Orellana A, Then Bergh F, Wang X, Hulsman M, Beker N, Tesi N, Morris CM, Indakoetxea B, Collij LE, Scherer M, Morenas-Rodríguez E, Ironside JW, van Berckel BNM, Alcolea D, Wiendl H, Strickland SL, Pastor P, Rodríguez Rodríguez E; DESGESCO (Dementia Genetics Spanish Consortium), EADB (Alzheimer Disease European DNA biobank); EADB (Alzheimer Disease European DNA biobank); IFGC (International FTD-Genomics Consortium), IPDGC (The International Parkinson Disease Genomics Consortium); IPDGC (The International Parkinson Disease Genomics Consortium); RiMod-FTD (Risk and Modifying factors in Fronto-Temporal Dementia); Netherlands Brain Bank (NBB), Boeve BF, Petersen RC, Ferman TJ, van Gerpen JA, Reinders MJT, Uitti RJ, Tárraga L, Maier W, Dols-Icardo O, Kawalia A, Dalmasso MC, Boada M, Zettl UK, van Schoor NM, Beekman M, Allen M, Masliah E, de Munain AL, Pantelyat A, Wszolek ZK, Ross OA, Dickson DW, Graff-Radford NR, Knopman D, Rademakers R, Lemstra AW, Pijnenburg YAL, Scheltens P, Gasser T, Chinnery PF, Hemmer B, Huisman MA, Troncoso J, Moreno F, Nohr EA, Sørensen TIA, Heutink P, Sánchez-Juan P, Posthuma D; GIFT (Genetic Investigation in Frontotemporal Dementia and Alzheimer’s Disease) Study Group, Clarimón J, Christensen K, Ertekin-Taner N, Scholz SW, Ramirez A, Ruiz A, Slagboom E, van der Flier WM, Holstege H.

Acta Neuropathol. 2019 Aug;138(2):237-250. doi: 10.1007/s00401-019-02026-8. Epub 2019 May 27.

2.

Custodiol-N™ cardioplegia lowers cerebral inflammation and activation of hypoxia-inducible factor-1α.

Hoyer A, Then Bergh F, Klaeske K, Lehmann S, Misfeld M, Borger M, Dieterlen MT.

Interact Cardiovasc Thorac Surg. 2019 Jun 1;28(6):884-892. doi: 10.1093/icvts/ivy347.

PMID:
30668864
3.

Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controls.

Schinke C, Hesse S, Rullmann M, Becker GA, Luthardt J, Zientek F, Patt M, Stoppe M, Schmidt E, Meyer K, Meyer PM, Orthgieß J, Blüher M, Kratzsch J, Ding YS, Then Bergh F, Sabri O.

Stress. 2019 Jan;22(1):93-102. doi: 10.1080/10253890.2018.1511698. Epub 2018 Oct 29.

PMID:
30369292
4.

Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions.

Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Hellwig K, Pache F, Ruprecht K, Havla J, Kümpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Stellmann JP, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Krumbholz M, Zeltner L, Ziemann U, Linker R, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Zettl UK, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C; NEMOS (Neuromyelitis Optica Study Group).

Neurol Neuroimmunol Neuroinflamm. 2018 Sep 26;5(6):e504. doi: 10.1212/NXI.0000000000000504. eCollection 2018 Nov.

5.

Compromised tDCS-induced facilitation of motor consolidation in patients with multiple sclerosis.

Rumpf JJ, Dietrich S, Stoppe M, Fricke C, Weise D, Then Bergh F, Classen J.

J Neurol. 2018 Oct;265(10):2302-2311. doi: 10.1007/s00415-018-8993-6. Epub 2018 Aug 6.

PMID:
30083954
6.

Ischaemic preconditioning of the spinal cord to prevent spinal cord ischaemia during endovascular repair of thoracoabdominal aortic aneurysm: first clinical experience.

Branzan D, Etz CD, Moche M, Von Aspern K, Staab H, Fuchs J, Then Bergh F, Scheinert D, Schmidt A.

EuroIntervention. 2018 Sep 20;14(7):828-835. doi: 10.4244/EIJ-D-18-00200.

7.

Beyond the limbic system: disruption and functional compensation of large-scale brain networks in patients with anti-LGI1 encephalitis.

Heine J, Prüss H, Kopp UA, Wegner F, Then Bergh F, Münte T, Wandinger KP, Paul F, Bartsch T, Finke C.

J Neurol Neurosurg Psychiatry. 2018 Nov;89(11):1191-1199. doi: 10.1136/jnnp-2017-317780. Epub 2018 Jun 9.

PMID:
29886429
8.

Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis.

Mueller SH, Färber A, Prüss H, Melzer N, Golombeck KS, Kümpfel T, Thaler F, Elisak M, Lewerenz J, Kaufmann M, Sühs KW, Ringelstein M, Kellinghaus C, Bien CG, Kraft A, Zettl UK, Ehrlich S, Handreka R, Rostásy K, Then Bergh F, Faiss JH, Lieb W, Franke A, Kuhlenbäumer G, Wandinger KP, Leypoldt F; German Network for Research on Autoimmune Encephalitis (GENERATE).

Ann Neurol. 2018 Apr;83(4):863-869. doi: 10.1002/ana.25216.

PMID:
29572931
9.

Treatment choices and neuropsychological symptoms of a large cohort of early MS.

von Bismarck O, Dankowski T, Ambrosius B, Hessler N, Antony G, Ziegler A, Hoshi MM, Aly L, Luessi F, Groppa S, Klotz L, Meuth SG, Tackenberg B, Stoppe M, Then Bergh F, Tumani H, Kümpfel T, Stangel M, Heesen C, Wildemann B, Paul F, Bayas A, Warnke C, Weber F, Linker RA, Ziemann U, Zettl UK, Zipp F, Wiendl H, Hemmer B, Gold R, Salmen A.

Neurol Neuroimmunol Neuroinflamm. 2018 Mar 1;5(3):e446. doi: 10.1212/NXI.0000000000000446. eCollection 2018 May.

10.

Outcome of MS relapses in the era of disease-modifying therapy.

Stoppe M, Busch M, Krizek L, Then Bergh F.

BMC Neurol. 2017 Aug 7;17(1):151. doi: 10.1186/s12883-017-0927-x.

11.

Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response.

Stellmann JP, Krumbholz M, Friede T, Gahlen A, Borisow N, Fischer K, Hellwig K, Pache F, Ruprecht K, Havla J, Kümpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Young KL, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker RA, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Zettl U, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C, Kleiter I; NEMOS (Neuromyelitis Optica Study Group).

J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):639-647. doi: 10.1136/jnnp-2017-315603. Epub 2017 Jun 1.

12.

The hidden Niemann-Pick type C patient: clinical niches for a rare inherited metabolic disease.

Hendriksz CJ, Anheim M, Bauer P, Bonnot O, Chakrapani A, Corvol JC, de Koning TJ, Degtyareva A, Dionisi-Vici C, Doss S, Duning T, Giunti P, Iodice R, Johnston T, Kelly D, Klünemann HH, Lorenzl S, Padovani A, Pocovi M, Synofzik M, Terblanche A, Then Bergh F, Topçu M, Tranchant C, Walterfang M, Velten C, Kolb SA.

Curr Med Res Opin. 2017 May;33(5):877-890. doi: 10.1080/03007995.2017.1294054. Epub 2017 Mar 2. Review.

PMID:
28276873
13.

Post-dexamethasone serum copeptin corresponds to HPA axis responsiveness in human obesity.

Schinke C, Hesse S, Stoppe M, Meyer K, Schmidt E, Orthgiess J, Bechmann L, Bresch A, Rullmann M, Luthardt J, Sabri O, Blüher M, Kratzsch J, Then Bergh F.

Psychoneuroendocrinology. 2017 Apr;78:39-47. doi: 10.1016/j.psyneuen.2017.01.004. Epub 2017 Jan 16.

PMID:
28167369
14.

Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis With Leucine-Rich, Glioma-Inactivated 1 Antibodies.

Finke C, Prüss H, Heine J, Reuter S, Kopp UA, Wegner F, Then Bergh F, Koch S, Jansen O, Münte T, Deuschl G, Ruprecht K, Stöcker W, Wandinger KP, Paul F, Bartsch T.

JAMA Neurol. 2017 Jan 1;74(1):50-59. doi: 10.1001/jamaneurol.2016.4226.

PMID:
27893017
15.

Lesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: a randomised, single-blind, phase II study.

Schwartzbach CJ, Grove RA, Brown R, Tompson D, Then Bergh F, Arnold DL.

J Neurol. 2017 Feb;264(2):304-315. doi: 10.1007/s00415-016-8341-7. Epub 2016 Nov 25.

16.

Influence of female sex and fertile age on neuromyelitis optica spectrum disorders.

Borisow N, Kleiter I, Gahlen A, Fischer K, Wernecke KD, Pache F, Ruprecht K, Havla J, Krumbholz M, Kümpfel T, Aktas O, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Weissert R, Stellmann JP, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker RA, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Winkelmann A, Marouf W, Rückriem L, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C, Hellwig K; NEMOS (Neuromyelitis Optica Study Group).

Mult Scler. 2017 Jul;23(8):1092-1103. doi: 10.1177/1352458516671203. Epub 2016 Oct 6.

PMID:
27758954
17.

Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation.

Andlauer TF, Buck D, Antony G, Bayas A, Bechmann L, Berthele A, Chan A, Gasperi C, Gold R, Graetz C, Haas J, Hecker M, Infante-Duarte C, Knop M, Kümpfel T, Limmroth V, Linker RA, Loleit V, Luessi F, Meuth SG, Mühlau M, Nischwitz S, Paul F, Pütz M, Ruck T, Salmen A, Stangel M, Stellmann JP, Stürner KH, Tackenberg B, Then Bergh F, Tumani H, Warnke C, Weber F, Wiendl H, Wildemann B, Zettl UK, Ziemann U, Zipp F, Arloth J, Weber P, Radivojkov-Blagojevic M, Scheinhardt MO, Dankowski T, Bettecken T, Lichtner P, Czamara D, Carrillo-Roa T, Binder EB, Berger K, Bertram L, Franke A, Gieger C, Herms S, Homuth G, Ising M, Jöckel KH, Kacprowski T, Kloiber S, Laudes M, Lieb W, Lill CM, Lucae S, Meitinger T, Moebus S, Müller-Nurasyid M, Nöthen MM, Petersmann A, Rawal R, Schminke U, Strauch K, Völzke H, Waldenberger M, Wellmann J, Porcu E, Mulas A, Pitzalis M, Sidore C, Zara I, Cucca F, Zoledziewska M, Ziegler A, Hemmer B, Müller-Myhsok B.

Sci Adv. 2016 Jun 17;2(6):e1501678. doi: 10.1126/sciadv.1501678. eCollection 2016 Jun.

18.

Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses.

Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Wegner B, Hellwig K, Pache F, Ruprecht K, Havla J, Krumbholz M, Kümpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Stellmann JP, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker R, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Winkelmann A, Marouf W, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C; Neuromyelitis Optica Study Group.

Ann Neurol. 2016 Feb;79(2):206-16. doi: 10.1002/ana.24554. Epub 2015 Nov 26.

PMID:
26537743
19.

Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array.

Dankowski T, Buck D, Andlauer TF, Antony G, Bayas A, Bechmann L, Berthele A, Bettecken T, Chan A, Franke A, Gold R, Graetz C, Haas J, Hecker M, Herms S, Infante-Duarte C, Jöckel KH, Kieseier BC, Knier B, Knop M, Kümpfel T, Lichtner P, Lieb W, Lill CM, Limmroth V, Linker RA, Loleit V, Meuth SG, Moebus S, Müller-Myhsok B, Nischwitz S, Nöthen MM, Paul F, Pütz M, Ruck T, Salmen A, Stangel M, Stellmann JP, Strauch K, Stürner KH, Tackenberg B, Then Bergh F, Tumani H, Waldenberger M, Weber F, Wiendl H, Wildemann B, Zettl UK, Ziemann U, Zipp F, Hemmer B, Ziegler A; German Competence Network for Multiple Sclerosis (KKNMS).

Genet Epidemiol. 2015 Dec;39(8):601-8. doi: 10.1002/gepi.21933. Epub 2015 Oct 26.

PMID:
26497834
20.

Corticosteroid receptor expression and in vivo glucocorticoid sensitivity in multiple sclerosis.

Bechmann L, Busse K, Stoppe M, Cotte S, Ettrich B, Then Bergh F.

J Neuroimmunol. 2014 Nov 15;276(1-2):159-65. doi: 10.1016/j.jneuroim.2014.07.004. Epub 2014 Jul 15.

PMID:
25175068
21.

Whole-brain diffusion tensor imaging in correlation to visual-evoked potentials in multiple sclerosis: a tract-based spatial statistics analysis.

Lobsien D, Ettrich B, Sotiriou K, Classen J, Then Bergh F, Hoffmann KT.

AJNR Am J Neuroradiol. 2014 Nov-Dec;35(11):2076-81. doi: 10.3174/ajnr.A4034. Epub 2014 Jul 3.

22.

Hypothalamo-pituitary-adrenal axis activity evolves differentially in untreated versus treated multiple sclerosis.

Kümpfel T, Schwan M, Weber F, Holsboer F, Trenkwalder C, Then Bergh F.

Psychoneuroendocrinology. 2014 Jul;45:87-95. doi: 10.1016/j.psyneuen.2014.03.012. Epub 2014 Apr 2.

PMID:
24845180
23.

Cerebellar manifestation of PML under fumarate and after efalizumab treatment of psoriasis.

Stoppe M, Thomä E, Liebert UG, Major EO, Hoffmann KT, Claßen J, Then Bergh F.

J Neurol. 2014 May;261(5):1021-4. doi: 10.1007/s00415-014-7311-1. Epub 2014 Mar 18. No abstract available.

PMID:
24638202
24.

Definition of primary and secondary glioblastoma--letter.

Werner P, Fritzsch D, Holland H, Bauer M, Krupp W, Hoffmann KT, Saur D, Then Bergh F, Sabri O, Barthel H.

Clin Cancer Res. 2014 Apr 1;20(7):2011-2. doi: 10.1158/1078-0432.CCR-13-3190. Epub 2014 Feb 20. No abstract available.

25.

Breastfeeding is associated with lower risk for multiple sclerosis.

Conradi S, Malzahn U, Paul F, Quill S, Harms L, Then Bergh F, Ditzenbach A, Georgi T, Heuschmann P, Rosche B.

Mult Scler. 2013 Apr;19(5):553-8. doi: 10.1177/1352458512459683. Epub 2012 Sep 4.

PMID:
22951352
26.

[Myasthenia gravis and thymolipoma: a rare variation of a well-known theme].

Schneider M, Eichfeld U, Beller A, Baum P, Claßen J, Then Bergh F.

Nervenarzt. 2012 Aug;83(8):1035-8. doi: 10.1007/s00115-012-3560-3. German. No abstract available.

PMID:
22653258
27.

Environmental factors in early childhood are associated with multiple sclerosis: a case-control study.

Conradi S, Malzahn U, Schröter F, Paul F, Quill S, Spruth E, Harms L, Then Bergh F, Ditzenbach A, Georgi T, Heuschmann P, Rosche B.

BMC Neurol. 2011 Oct 6;11:123. doi: 10.1186/1471-2377-11-123.

28.

Improving test-retest variability of visual-evoked responses in multiple sclerosis: implications for trial design.

Thomae E, Niklas A, Sebraoui H, Baum P, Wagner A, Then Bergh F.

J Clin Neurophysiol. 2010 Aug;27(4):270-3. doi: 10.1097/WNP.0b013e3181eaa9e3.

PMID:
20634712
29.

[Wilson's disease and multiple sclerosis. Co-occurrence].

Günther P, Baum P, Then Bergh F, Hermann W.

Nervenarzt. 2010 Feb;81(2):226-8. doi: 10.1007/s00115-009-2876-0. German.

PMID:
19851743
30.

Outcome measures for trials of remyelinating agents in multiple sclerosis: retrospective longitudinal analysis of visual evoked potential latency.

Niklas A, Sebraoui H, Hess E, Wagner A, Then Bergh F.

Mult Scler. 2009 Jan;15(1):68-74. doi: 10.1177/1352458508095731. Epub 2008 Aug 13.

PMID:
18701569
31.

The clock keeps ticking for intravenous methylprednisolone.

Then Bergh F.

J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):788. No abstract available.

32.

Responsiveness to a dopamine agent in Holmes tremor--case report.

Strecker K, Schneider JP, Sabri O, Wegner F, Then Bergh F, Schwarz J, Hesse S.

Eur J Neurol. 2007 Apr;14(4):e9-e10. No abstract available.

PMID:
17388980
33.

Acute and chronic neuroendocrine effects of interferon-beta 1a in multiple sclerosis.

Then Bergh F, Kümpfel T, Yassouridis A, Lechner C, Holsboer F, Trenkwalder C.

Clin Endocrinol (Oxf). 2007 Feb;66(2):295-303.

PMID:
17224002
34.

Rapid progression of Myelodysplastic syndrome to acute myeloid leukemia on sequential azathioprine, IFN-beta and copolymer-1 in a patient with multiple sclerosis.

Then Bergh F, Niklas A, Strauss A, von Ahsen N, Niederwieser D, Schwarz J, Wagner A, Al-Ali HK.

Acta Haematol. 2006;116(3):207-10.

PMID:
17016041
35.

Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.

Then Bergh F, Kümpfel T, Schumann E, Held U, Schwan M, Blazevic M, Wismüller A, Holsboer F, Yassouridis A, Uhr M, Weber F, Daumer M, Trenkwalder C, Auer DP.

BMC Neurol. 2006 May 23;6:19.

36.

Subcortical Right Parietal AVM Rotational vertigo and caloric stimulation fMRI support a parietal representation of vestibular input.

Schneider JP, Reinohs M, Prothmann S, Puccini S, Dalitz B, Schwarz J, Zimmer C, Then Bergh F.

J Neurol. 2006 Feb;253(2):253-5. Epub 2005 Aug 19. No abstract available.

PMID:
16096816
38.

Interferon beta but not glatiramer acetate therapy aggravates headaches in MS.

Pöllmann W, Erasmus LP, Feneberg W, Then Bergh F, Straube A.

Neurology. 2002 Aug 27;59(4):636-9.

PMID:
12196668
39.

Activity of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: correlations with gadolinium-enhancing lesions and ventricular volume.

Schumann EM, Kümpfel T, Then Bergh F, Trenkwalder C, Holsboer F, Auer DP.

Ann Neurol. 2002 Jun;51(6):763-7.

PMID:
12112083
40.

Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response.

Derfuss T, Gürkov R, Then Bergh F, Goebels N, Hartmann M, Barz C, Wilske B, Autenrieth I, Wick M, Hohlfeld R, Meinl E.

Brain. 2001 Jul;124(Pt 7):1325-35.

PMID:
11408328
41.
42.

Treatment of multiple sclerosis with Copaxone (COP): Elispot assay detects COP-induced interleukin-4 and interferon-gamma response in blood cells.

Farina C, Then Bergh F, Albrecht H, Meinl E, Yassouridis A, Neuhaus O, Hohlfeld R.

Brain. 2001 Apr;124(Pt 4):705-19.

PMID:
11287371
44.

Acute effects of interferon beta-1a on plasma cytokine levels in patients with MS.

Kümpfel T, Then Bergh F, Pollmächer T, Holsboer F, Trenkwalder C.

Neurology. 2000 Oct 24;55(8):1231-3.

PMID:
11071509
45.

Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells.

Neuhaus O, Farina C, Yassouridis A, Wiendl H, Then Bergh F, Dose T, Wekerle H, Hohlfeld R.

Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7452-7.

46.

Comparison of nucleosome remodeling by the yeast transcription factor Pho4 and the glucocorticoid receptor.

Then Bergh F, Flinn EM, Svaren J, Wright AP, Hörz W.

J Biol Chem. 2000 Mar 24;275(12):9035-42.

47.

Dehydroepiandrosterone response to the adrenocorticotropin test and the combined dexamethasone and corticotropin-releasing hormone test in patients with multiple sclerosis.

Kümpfel T, Then Bergh F, Friess E, Uhr M, Yassouridis A, Trenkwalder C, Holsboer F.

Neuroendocrinology. 1999 Dec;70(6):431-8.

PMID:
10657736
48.

Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS.

Then Bergh F, Kümpfel T, Trenkwalder C, Rupprecht R, Holsboer F.

Neurology. 1999 Sep 11;53(4):772-7.

PMID:
10489039
49.

Magnetic resonance proton spectroscopy of the brain in Wilson's disease.

Kraft E, Trenkwalder C, Then Bergh F, Auer DP.

J Neurol. 1999 Aug;246(8):693-9.

PMID:
10460447
50.

Binding characteristics of the glucocorticoid receptor in peripheral blood lymphocytes in multiple sclerosis.

Then Bergh F, Grasser A, Trenkwalder C, Backmund H, Holsboer F, Rupprecht R.

J Neurol. 1999 Apr;246(4):292-8.

PMID:
10367698

Supplemental Content

Loading ...
Support Center